Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026)

Novartis Ag has reported Goodwill & Intangibles for 18 years, with the latest figure at $68.8 billion in Q2 2026.

• Quarterly Goodwill & Intangibles rose 25.64% year-over-year to $68.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $68.8 billion (up 25.64% YoY) and the FY2025 annual result came in at $55.0 billion, up 6.4% from the prior year.
• Goodwill & Intangibles grew to $68.8 billion in Q2 2026 per NVS's latest filing, from $12.7 billion in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $99.0 billion in Q4 2022 and troughed at $148.0 million in Q1 2022.
• A 5-year average of $47.3 billion and a median of $53.9 billion in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles surged 71.56% in 2023, then slumped 36.72% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $99.0 billion in 2022, then slipped by 17.5% to $81.7 billion in 2023, then plunged by 36.72% to $51.7 billion in 2024, then grew by 6.4% to $55.0 billion in 2025, then climbed by 25.22% to $68.8 billion in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $68.8 billion, $12.7 billion, and $55.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.